http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6380171-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5cf811e10ad9068ddf72c04b69c8ba8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee630d0c502df0337f3090d22715775a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c107885356c8d901439968aec40efeb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6454
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-57
filingDate 1997-07-25^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2002-04-30^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd4484502e6ffeda202c264c01f94086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89f7c60205ea46cdb3872e0fc68989a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce255f701e7e021edba4dccf3fddad18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b466eccd63c88179d28182832a059510
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71a8c6a2102e37c0dd2bbb7fbbe1f222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23bd82074072bdd66d76cdcdc8bf2061
publicationDate 2002-04-30^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6380171-B1
titleOfInvention Pro-protein converting enzyme
abstract The present invention relates to the cloning of human pro-protein converting enzyme 5 (PC5) CDNA isolated from human adrenal gland messenger RNA. Additionally, this invention relates to a method for reducing restenosis occurring at an injured vascular site comprising delivering to the injured site an antisense nucleic acid to suppress the expression of human PC5.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9856468-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7795400-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11168316-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010015659-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009130691-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10968442-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3560962-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007112005-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2650305-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7566565-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11261437-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007259402-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10287564-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011053222-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10202595-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009068698-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012006635-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012006633-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016070050-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11642398-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9611310-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013185114-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016065301-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11168125-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8021880-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10927362-B2
priorityDate 1996-07-26^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5866351-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9415945-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66577194
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID316250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID172198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413394
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10351092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127621275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6540254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127986152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128954713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405859
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136326756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID320930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127548708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID247704
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816

Showing number of triples: 1 to 88 of 88.